NL-OMON55653招募中不适用
The BITE study - Bleeding In Thrombocytopenia Explained: A nationwide epidemiological and laboratory case cohort study investigating risk factors for bleeding in hemato-oncology patients - The BITE study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 1,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Admission in the hospital
- •- Age >= 18 years
- •- Hemato-oncology patient, including MDS and AA, admitted for treatment
- •(chemotherapy, SCT) who is (expected to become) thrombocytopenic with platelet
- •counts of < 50 for expected at least 5 days and who will possibly be treated
- •with one or more prophylactic platelet transfusions. (part A and B)
- •- Hemato-oncology patient who had previous intensive chemotherapy or stem cell
- •transplantation and who is admitted to the hematology ward for disease or
- •treatment related events or complications. (part A only)
排除标准
- •- Myeloproliferative disorders
研究者
相似试验
已完成
不适用
Which is better in viral fever? kiwi or guavaCTRI/2022/07/043922ONE100
招募中
不适用
Bleeding In Thrombocytopenia ExplainedPlatelet TransfusionBleedingHemorrhageHematologic NeoplasmsNCT03505086Sanquin-LUMC J.J van Rood Center for Clinical Transfusion Research1,000
已完成
不适用
The Bleeding with Antithrombotic Therapy Study 2Cerebrovascular and cardiovascular diseasesJPRN-UMIN000023669ational Cerebral and Cardiovascular Center5,367
终止
2 期
Thrombocytopenia and Bleeding in Wiskott-Aldrich Syndrome (WAS) PatientsWiskott-Aldrich SyndromeBleedingThrombocytopeniaNCT00909363Weill Medical College of Cornell University24
已完成
2 期
Platenza Tablets for Dengue feverCTRI/2018/03/012738The Himalaya Drug Company60